Skip to content

How to Cycle Peptides

Peptide cycling refers to the practice of using a peptide for a set period (the 'on' phase) followed by a break (the 'off' phase) before resuming. Cycling can help maintain receptor sensitivity, reduce the risk of side effects, and potentially improve long-term results. Not every peptide requires strict cycling, but understanding when and how to cycle is a key part of responsible peptide use.

Last updated: 2026-03-03

What You'll Need

  • Written log or spreadsheet for tracking on/off dates
  • Calendar reminders for cycle transitions
  • Reconstituted peptide vials for the current cycle
  • Blood-work requisition (recommended at cycle start and end)

Steps

1

Identify your peptide class and default cycle length

Different peptide categories have different recommended cycle lengths. GH secretagogues typically run 8-12 weeks on, healing peptides 4-8 weeks, and fat-loss peptides 8-12 weeks. Check the compound-specific section below for your peptide.

2

Set a clear start date and mark your calendar

Record the exact date you begin. Set calendar reminders for the halfway point (to assess progress) and the planned end date. Consistent tracking prevents accidental overextension of cycles.

3

Monitor for signs of receptor desensitization

During your on phase, watch for diminishing returns — reduced effects at the same dose, need for higher doses to achieve the same result, or new side effects appearing. These can indicate receptor downregulation and suggest it is time to cycle off.

4

Transition to the off phase

When your on phase ends, stop the peptide completely. For GH secretagogues, some practitioners taper the dose over 3-5 days rather than stopping abruptly. During the off phase, receptors resensitize and your body returns to baseline signaling.

5

Use the off phase productively

The off phase is not wasted time. Maintain your training, nutrition, and sleep. Consider running blood work 2-3 weeks into the off phase to check biomarkers like IGF-1, fasting glucose, and liver/kidney panels. This data informs your next cycle.

6

Evaluate and plan your next cycle

After the off period, review your log. Did the peptide achieve its goal? Were side effects manageable? Adjust your next cycle length or dose based on the data. If results were strong with minimal sides, you can repeat the same protocol. If diminishing returns occurred early, consider a longer off phase or a lower dose.

Why Cycle Peptides?

Peptide cycling serves several purposes supported by pharmacological principles:

  • Receptor sensitivity: Continuous stimulation of a receptor can lead to downregulation — the cell reduces the number of available receptors or decreases their sensitivity. Cycling allows receptors to "reset," maintaining the peptide's effectiveness over time[1]
  • Hormonal homeostasis: Peptides that influence growth hormone, insulin, or other hormones can shift your body's baseline if used indefinitely. Breaks allow your endocrine system to return to its natural setpoints
  • Side-effect management: Some side effects (water retention, numbness/tingling, appetite changes) are cumulative. Regular breaks reduce the chance of chronic issues
  • Cost efficiency: Cycling means you use fewer vials over a 12-month period compared to continuous use, which can significantly reduce cost

Not all peptides require cycling with equal urgency. The necessity depends primarily on the peptide's mechanism of action and how it interacts with receptor systems.

Which Peptides Need Cycling?

Peptide Class Examples Cycling Needed? Typical On/Off
GH Secretagogues Sermorelin, Ipamorelin, CJC-1295, Hexarelin Yes — strongly recommended 8–12 weeks on / 4–6 weeks off
Healing / Repair BPC-157, TB-500, Thymosin Beta-4 Often goal-dependent 4–8 weeks on / 2–4 weeks off
Fat-Loss Peptides AOD-9604, Tesofensine Recommended 8–12 weeks on / 4 weeks off
GLP-1 Agonists Semaglutide, Tirzepatide, Retatrutide Typically continuous (Rx) Ongoing per prescriber guidance
Nootropic Peptides Semax, Selank, Dihexa Recommended 4–6 weeks on / 2–4 weeks off
Longevity / Mitochondrial Epitalon, MOTS-c, SS-31 Protocol-dependent 10–20 days on / 4–6 months off (Epitalon); 4–8 weeks on / 4 weeks off (MOTS-c)

GH Secretagogue Cycling Protocols

Growth hormone secretagogues are the peptide class where cycling matters most. These peptides work by stimulating the pituitary gland to release more GH. Continuous, uninterrupted use can lead to pituitary desensitization — the gland produces less GH in response to the same signal over time[2].

Standard GH Secretagogue Cycle

  • On phase: 8–12 weeks at a consistent daily dose
  • Off phase: 4–6 weeks with no GH secretagogue use
  • Dosing frequency: Most secretagogues are dosed once or twice daily, typically before bed and/or upon waking (fasted)

The Ipamorelin + CJC-1295 Cycle

The ipamorelin and CJC-1295 stack is the most popular GH secretagogue combination. A common cycle looks like this:

  • Weeks 1–12: Ipamorelin 200–300 mcg + CJC-1295 (no DAC) 100 mcg, injected together subcutaneously before bed
  • Weeks 13–16: Off phase — no secretagogues
  • Week 17: Resume cycle if desired

For Hexarelin, cycles are often shorter (4–8 weeks) because hexarelin causes more pronounced desensitization than ipamorelin. Read more in our CJC-1295 + ipamorelin stack guide.

Healing Peptide Cycling Protocols

Healing peptides like BPC-157 and TB-500 are often used to address a specific injury or condition. Cycling these peptides is less about receptor desensitization (BPC-157 works through multiple pathways, not a single receptor) and more about assessing whether the therapeutic goal has been met.

Injury-Focused Protocol

  • Acute phase: 4–6 weeks at full dose (e.g., BPC-157 250–500 mcg/day)
  • Assessment: Evaluate healing progress — pain levels, range of motion, imaging if applicable
  • Decision: If healed, discontinue. If improving but not resolved, take 2 weeks off and run another 4-week cycle

The BPC-157 + TB-500 stack is commonly run for 6–8 weeks for moderate-to-severe injuries. Check our dosage guide for compound-specific dosing ranges.

Maintenance / Prevention Protocol

Some users run low-dose BPC-157 (100–250 mcg/day) for gut health or general recovery support. In this context, cycling 4 weeks on / 2 weeks off is a reasonable approach to avoid unnecessary continuous use.

Signs You Should Cycle Off

Even within a planned cycle, these warning signs suggest you should begin your off phase early:

  • Diminishing returns: The effects you initially noticed (better sleep, faster recovery, fat loss) have stalled or reversed despite consistent dosing
  • Increased side effects: Water retention, joint stiffness, carpal tunnel symptoms, or persistent numbness/tingling in extremities (common with GH elevation)
  • Elevated fasting glucose: GH secretagogues can raise blood sugar over time. If fasting glucose rises above 100 mg/dL on blood work, consider cycling off[3]
  • Mood or sleep disruption: Some peptides can affect sleep architecture or mood with extended use
  • Blood work abnormalities: Elevated IGF-1 beyond the reference range, changes in liver or kidney markers, or other unexpected lab results

When in doubt, err on the side of cycling off. You can always resume after a break.

Tracking Your Cycles Effectively

Keeping a cycle log helps you optimize future protocols. Record the following for each cycle:

  • Peptide name, dose, and frequency
  • Start and end dates of on/off phases
  • Subjective effects — energy, sleep quality, recovery speed, body composition changes (weekly notes)
  • Side effects — type, severity, when they appeared
  • Blood work — pre-cycle, mid-cycle (optional), and post-cycle panels

A simple spreadsheet works well for tracking. Review your log before starting each new cycle to identify what worked and what to adjust.

Related Tools & Guides

Frequently Asked Questions

References

  1. Catt KJ, Harwood JP, Aguilera G, Dufau ML. Hormonal regulation of peptide receptors and target cell responses. Nature, 1979.
  2. Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J Clin Endocrinol Metab, 1998.
  3. Møller N, Jørgensen JOL. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews, 2009.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.